Skip Navigation

What's the deali-O Part 2: Navigating new weight loss drugs

scopeblog.stanford.edu What's the deali-O Part 2: Navigating new weight loss drugs

Stanford Medicine obesity experts discuss the pros and cons of semaglutide, the active ingredient in Ozempic and other weight loss drugs.

What's the deali-O Part 2: Navigating new weight loss drugs
0
0 comments